| 產品名稱 |
U937-DC-SIGN |
| 商品貨號 |
B179868 |
| Organism |
Homo sapiens, human |
| Tissue |
pleural effusion |
| Cell Type |
lymphocyte |
| Product Format |
frozen |
| Morphology |
lymphocyte-like |
| Culture Properties |
suspension |
| Biosafety Level |
2 [Cells contain SV-40 and CMV viral DNA sequences]
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease |
histiocytic lymphoma |
| Age |
37 years |
| Gender |
male |
| Ethnicity |
Caucasian |
| Applications |
Study Dengue virus infection, as Dengue virus uses DC-SIGN as an attachment factor. Useful for measuring antibody-mediated neutralization and enhancement in flow cytometry-based neutralization assays. |
| Storage Conditions |
liquid nitrogen vapor phase |
| Images |
 |
| Derivation |
The U-937-DC-SIGN cell line was developed by transducing U-937 cells with the gene for human DC SIGN protein (Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin), a known attachment factor for Dengue viruses. The cloning vector used was pcDNA3 which contains SV-40 and CMV promoter regions. |
| Clinical Data |
37 years
Caucasian
male |
| Antigen Expression |
dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) |
| Comments |
This cell line was developed by stably transfecting U-937 cells (ATCC® No. CRL-1593.2™) with pcDNA3-DC-SIGN plasmid. |
| Complete Growth Medium |
ATCC® Medium 7318: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium:
- an additional 2 mM L-glutamine
- non-essential amino acids to a final concentration of 0.1 mM
- 2-mercaptoethanol to a final concentration of 0.05 mM
- fetal bovine serum to a final concentration of 5%
|
| Subculturing |
Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 x 105 to 2 x 105 viable cells/mL.
Interval: Maintain cell density between 1 X 105 and 2 X 106 viable cells/mL.
Medium Renewal: Add fresh medium every 3 to 4 days (depending on cell density). |
| Culture Conditions |
Temperature: 37°C
Atmosphere: air, 95%; carbon dioxide (CO2), 5% |
| STR Profile |
Amelogenin: X
CSF1PO: 12
D13S317: 10,12
D16S539: 12
D5S818: 12
D7S820: 9, 11
THO1: 6, 9.3
TPOX: 8,11
vWA: 14,15 |
| Name of Depositor |
A. Desilva |
| Year of Origin |
January 2008 |
| References |
Kraus A, et al. Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization. J. Clin. Microbiol. 45(11): 3777-3780, 2007. PubMed: 17804661
|